139102-34-4

Basic information

• Product Name: METHYL 4-BROMO-2-METHOXYBENZOATE 98
• Synonyms: METHYL 4-BROMO-2-METHOXYBENZOATE 98;METHYL 4-BROMO-2-METHOXYBENZOATE, PURISS;Methyl 4-bromo-2-methoxybenzoate 98%;4-BROMO-2-METHOXYBENZOATE;2-methoxy-4-bromobenzoate
• CAS NO: 139102-34-4
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245.071
• Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;Acids & Esters;Anisoles, Alkyloxy Compounds & Phenylacetates;Bromine Compounds;C8 to C9;Carbonyl Compounds;Esters
• Mol File: 139102-34-4.mol
• Article Data: 14

Chemical Properties

• Melting Point: 33 °C(lit.)
• Boiling Point: 52 °C0.01 mm Hg(lit.)
• Flash Point: >230 °F
• Appearance: /low-melting solid
• Density: 1.463 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.538
• Storage Temp.: Room temperature.
• Solubility: soluble in Toluene
• CAS DataBase Reference: METHYL 4-BROMO-2-METHOXYBENZOATE 98(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-BROMO-2-METHOXYBENZOATE 98(139102-34-4)
• EPA Substance Registry System: METHYL 4-BROMO-2-METHOXYBENZOATE 98(139102-34-4)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• RIDADR: UN 2811 6.1/PG 3
• WGK Germany: 3
• PackingGroup: III
• Hazardous Substances Data: 139102-34-4(Hazardous Substances Data)

Usage

Chemical Properties

White powder

InChI:InChI=1/C9H9BrO3/c1-12-8-5-6(10)3-4-7(8)9(11)13-2/h3-5H,1-2H3

Upstream product

• 1666-28-0 4-bromosalicylic acid 
• 74-88-4 methyl iodide 
• 72135-36-5 4-bromo-2-methoxybenzoic acid 
• 22717-56-2 4-bromo-2-Hydroxybenzoic Acid Methylester 
• 77-78-1 dimethyl sulfate 
• 67-56-1 methanol 

Downstream Products

• 17102-63-5 (4-bromo-2-methoxyphenyl)methanol 
• 72135-36-5 4-bromo-2-methoxybenzoic acid 
• 908247-92-7 methyl 2-methoxy-4-(3,3-dimethylbut-1-ynyl)benzoate 
• 1045771-51-4 2-methoxy-4-[2-(trimethylsilanyl)ethanesulfonylamino]benzoic acid methyl ester 
• 1173176-99-2 methyl 2-methoxy-4-(3-methylisoxazol-5-yl)benzoate 
• 1246765-42-3 methyl 4-(1-ethoxyvinyl)-2-methoxybenzoate 
• 1257310-64-7 3-methoxy-4-(2-trimethylsilanylethoxycarbonylamino)benzoic acid methyl ester 
• 1256497-72-9 methyl 4-(4-(tert-butyldimethylsilyloxy)but-1-ynyl)-2-methoxybenzoate 
• 1338209-73-6 methyl 4-(1,1-dimethylethylsulfinamido)-2-methoxybenzoate 
• 1364267-50-4 methyl 4-(2-amino-5-bromopyridin-3-yl)-2-methoxybenzoate 
• 1364267-61-7 C₁₄H₁₅BN₂O₅ 
• 1364267-87-7 methyl 4-(2-amino-5-(thiophen-2-yl)pyridin-3-yl)-2-methoxybenzoate 
• 1364267-95-7 methyl 4-(2-amino-5-(4-((dimethylamino)methyl)thiophen-2-yl)pyridin-3-yl)-2-methoxybenzoate 
• 1364268-90-5 4-(2-amino-5-(thiophen-2-yl)pyridin-3-yl)-2-methoxybenzamide 

Relevant articles and documents

Highly selective electroreductive linear dimerization of electron-deficient vinylarenes

A direct electroreductive dimerization of electron-deficient vinylarenes for the synthesis of 1,4-diarylbutane has been developed using a simple undivided cell with inexpensive carbon electrodes at room temperature. The control and deuterium-labeling experiments of electroreductive dimerization suggest that the hydrogen source comes from the solvent CH3CN. This protocol provides a mild and efficient route for the construction of C–C bond in moderate to good yields with high regioselectivity and broad substrate scope.

CANCER TREATMENTS TARGETING CANCER STEM CELLS

Disclosed are compounds, methods, compositions, and kits that allow for treating cancer by, e.g., targeting cancer stem cells. In some embodiments, the cancer is colorectal cancer, gastric cancer, gastrointestinal stromal tumor, ovarian cancer, lung cancer, breast cancer, pancreatic cancer, prostate cancer, testicular cancer, or lymphoma. In some embodiments, the cancer is liver cancer, endometrial cancer, leukemia, or multiple myeloma. The compounds utilized in the disclosure are of Formula (0), (O'), and (I):

METHOD FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1-6-NAPHTHYRIDINE-3-CARBOXAMIDE AND RECOVERY OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1-6-NAPHTHYRIDINE-3-CARBOXAMIDE BY ELECTROCHEMICAL METHODS

The present invention relates to a novel process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of the formula (I) and recovering (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of the formula (I) proceeding from (4R)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of the formula ent-(I)